GlassScriptPhysician profile
Laura R Daily
NPI 1982961728
$3,563.16
in general payments reported to CMS, 2019-2025
22 companies · $579 in 2025
The $579 reported for 2025 was more than what 78% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $664 · 2020: $184 · 2021: $235 · 2022: $237 · 2023: $828 · 2024: $836 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,243.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $589.23 | 2021-2025 | |
| Glaxosmithkline, LLC. | $484.92 | 2020-2025 | Jemperli, Zejula |
| Merck Sharp & Dohme LLC | $425.19 | 2019-2025 | Keytruda, Lynparza |
| Genmab U.S., INC. | $401.39 | 2021-2025 | Tivdak |
| Astrazeneca Pharmaceuticals LP | $278.92 | 2019-2025 | Lynparza, Enhertu |
| Clovis Oncology, INC. | $249.89 | 2019-2022 | |
| Tesaro, INC. | $221.74 | 2019 | |
| Ethicon US, LLC | $210.72 | 2019-2020 | |
| Seagen INC. | $127.68 | 2023 | |
| Abbvie INC. | $110.31 | 2021-2025 | |
| Davol INC. | $110.26 | 2024 | Arista Ah Flexitip |
| Myriad Genetic Laboratories, INC. | $87.75 | 2021-2024 | Mychoice Cdx, Precisetumor |
| Tempus Ai, INC | $50.51 | 2024 | |
| Becton, Dickinson and Company | $45.07 | 2022 | |
| Immunogen, INC. | $34.72 | 2023 | Elahere |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $23.39 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Hologic Sales and Service, LLC | $23.24 | 2025 | Novasure, Myosure Tissue Removal Device |
| Fennec Pharmaceuticals, INC. | $22.97 | 2025 | Fyarro |
| Astellas Pharma US INC | $20.87 | 2025 | Veozah |
| Caris Mpi, INC. | $18.55 | 2025 | Mi Cancer Seek |
| Jazz Pharmaceuticals INC. | $13.59 | 2019 | |
| Boston Scientific Corporation | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Daily listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.